(2) Patients with major heart, liver, kidney, and other organ disorders, including co-infection with hepatitis C virus (HCV), hepatitis D virus (HDV), or other chronic liver diseases such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and autoimmune hepatitis
PlexusDx recommends stopping dose increases once you reach consistent weight loss with manageable side effects, rather than automatically climbing to the labeled maximum
After reconstitution, refrigeration is required
If the temperature change to the heart is rapid, ventricular fibrillation may result
Around 64% of the study covers regional insights across North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting market share distribution and demand patterns